In addition, our management has identified qualified individuals that may comprise the Scientific Advisory Panel in the future. The individuals are highly respected and well-established in their respective fields of practice. From time to time, management currently consults with such individuals on technical advice.
Dr. Mishra is an early member of the company and serves as a Director for Product Development of complex molecules and sterile injectables. He is also responsible for new formulations using proprietary novel delivery systems using biocompatible polymers and prodrug approach. Additionally, he is overseeing projects which are outsourced to CRO, CMO and strategic manufacturing partners. Before joining Dynamic, he was a Research Faculty in Johns Hopkins Medical School at Center for Nanomedicine, Baltimore. In the center, he has developed biomaterials based targeted delivery systems for brain diseases like Cerebral palsy, Autism, Brain Cancer (glioblastoma); and eye diseases like AMD, Retinitis pigmentosa, Diabetic retinopathy; and Hypothermic Cardiac arrest disease. He has extensive experience in formulating and characterizing polymeric DNA nanoparticles for eye diseases and sexually-transmitted disease (STD). Prior to coming to United State he served as a Research Scientist in Sun Pharmaceuticals, Gurgaon (formerly Ranbaxy Research Lab.) and as a QA Chemist in Dabur India Limited, Sahibabad. He is the author of more than 35 peer-reviewed research papers in medicinal, biomaterials and drug delivery journals and scientific contribution as co-inventor in 5 patents.
Dr. Mishra received his Ph.D. degree in Chemistry from University of Delhi, Delhi. He has successfully completed postdoctoral fellowship in pharmaceutical and medicinal chemistry (neuroscience and eye disease) at University of Nebraska Medical Center, Omaha and Wayne State University, Detroit.
Dr. Peddareddygari serves as the Director for clinical and biological programs for complex molecules in R&D department. Prior to joining Dynamic Biologics she worked as the Scientific Director at the Neuro-genetics Institute, Sharon Hill, PA, where she was involved in organizing and developing a research team for pursuing rare disease genomics.As a Co-Investigator at St. Francis Medical Center, Trenton, she established the ischemic stroke dataset that is a part of the NINDS stroke genetics network (SiGN): the international stroke genetics consortium conducting genome-wide association studies of stroke. She also serves as the Scientific Advisor for the Neurogenetics Foundation, Cranbury, NJ, where she is involved in studies exploring the mutational genetics of various neuromuscular diseases and research projects focused onidentifying new targets and genetic biomarkers for diagnosis and treatment of migraine, vertigo and myopia. Dr. Peddareddygari received her MBBS degree from Sri Venkateshwara Medical College, Tirupati, and her MD in Pharmacology from the University of Madras, Chennai, India. She completed a postdoctoral fellowship in Neurogenetics at the New Jersey Neuroscience Institute, Edison, NJ.